Thyroglobulin measurement in the management of patients with differentiated thyroid cancer
The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
Abstract
The post-operative management of patients with differentiated thyroid carcinoma (DTC) relies on serial measurements of serum thyroglobulin. Current methodologies for thyroglobulin quantitation vary in their analytical and clinical performance. For years, thyroglobulin radioimmunoassays (RIA) and immunometric assays (IMA) have been used despite analytical interferences from anti-thyroglobulin autoantibodies (TgAb) as well as heterophile antibodies (HAb). TgAb interference limits Tg utility as a tumor marker in ∼30% of TgAb-positive patients. Consequently, additional studies are necessary to rule out persistent or recurrent disease in these patients. Recently, thyroglobulin mass spectrometry assays have been introduced as a solution to the interference problems observed in immunoassays. However, their analytical sensitivity is inferior to the high sensitivity immunoassays. The aims of this review are to: (i) review current thyroglobulin assays; (ii) discuss technical limitations of each assay; and (iii) discuss the clinical uses of thyroglobulin in serum and fine-needle aspirate biopsy washouts for the management of DTC patients. An understanding of the technical advantages and disadvantages of Tg assays is critical for clinicians and laboratorians to effectively use and interpret this test in the management of DTC patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, increased serum TG concentrations can also be found in subjects with other thyroid diseases, such as thyroiditis, increased thyroid activity, goiter, or Graves' disease [4,34].”
In the citing paper
“TG measurement is a useful marker for patient monitoring after DTC tumor removal and treatment [34]”
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21387 · Cited by 14,712
Hollowell, J. G., Staehling, N. W., Flanders, W. D., Hannon, W. H., Gunter, E. W., Spencer, C. A., & Braverman, L. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.2.489 · Cited by 4,279
Pacini, F., Schlumberger, M., Dralle, H., Elisei, R., Smit, J. W. A., Wiersinga, W., & _, _. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02158 · Cited by 1,976
Hundahl, S. A., Fleming, I. D., Fremgen, A. M., & Menck, H. R. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19981215)83:12<2638::aid-cncr31>3.0.co;2-1 · Cited by 1,836
Gharib, H., Papini, E., Garber, J. R., Duick, D. S., Harrell, R. M., Hegedus, L., Paschke, R., Valcavi, R., & Vitti, P. (2016) · Endocrine Practice · doi:10.4158/ep161208.gl · Cited by 1,272
Laboratory Support for the Diagnosis and Monitoring of Thyroid Disease
(2003) · Thyroid · doi:10.1089/105072503321086962 · Cited by 1,212
Sherma, S. I. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12488-9 · Cited by 925
Anderson, N. L., Anderson, N. G., Haines, L. R., Hardie, D. B., Olafson, R. W., & Pearson, T. W. (2004) · Journal of Proteome Research · doi:10.1021/pr034086h · Cited by 804
Haugen, B. R. (2017) · Cancer · doi:10.1002/cncr.30360 · Cited by 683
Gharib, H., Papini, E., Valcavi, R., Baskin, H. J., Crescenzi, A., Dottorini, M. E., Duick, D. S., Guglielmi, R., Hamilton, C. R., Zeiger, M. A., et al. (2006) · Endocrine Practice · doi:10.4158/ep.12.1.63 · Cited by 681
Research works printed but not linked: 6
- Feldt-Rasmussen U, 1996, Ann Biol Clin, 54, 337
- Feldt-Rasmussen U, 1996, Ann Biol Clin, 54, 343
- Ozata M, 1994, J Clin Endocrinol Metab, 79, 98
- Spencer CA, 1998, J Clin Endocrinol Metab, 83, 1121
- 10.1210/jcem.87.2.8182 · doi:10.1210/jcem.87.2.8182 · Paper page
- Pacini F, 1992, J Clin Endocrinol Metab, 74, 1401
Cited by
Ringel, M. D., Sosa, J. A., Baloch, Z., Bischoff, L., Bloom, G., Brent, G. A., Brock, P. L., Chou, R., Flavell, R. R., Goldner, W., et al. (2025) · Thyroid® · doi:10.1177/10507256251363120 · Cited by 710
Campennì, A., Barbaro, D., Guzzo, M., Capoccetti, F., & Giovanella, L. (2020) · Endocrine · doi:10.1007/s12020-020-02418-x · Cited by 72
Thyroglobulin and thyroglobulin antibody: an updated clinical and laboratory expert consensus
Giovanella, L., D’Aurizio, F., Algeciras‐Schimnich, A., Görges, R., Ovčariček, P. P., Tuttle, R. M., Visser, W. E., Verburg, F. A., hsTg&TgAb Consensus Working Group, Borowczyk, M., et al. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad109 · Cited by 56
Self-citationBottani, M., Aarsand, A. K., Banfi, G., Locatelli, M., Coşkun, A., Díaz-Garzón, J., Fernandez-Calle, P., Sandberg, S., Ceriotti, F., & Carobene, A. (2022) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2020-1885 · Cited by 46
“Moreover, increased serum TG concentrations can also be found in subjects with other thyroid diseases, such as thyroiditis, increased thyroid activity, goiter, or Graves’ disease [4, 34].”
Li, S., Ren, C., Gong, Y., Ye, F., Tang, Y., Xu, J., Guo, C. J., & Huang, J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.872527 · Cited by 48
“However, the analytical sensitivity of LC-MS/MS was inferior and it could not detect Tg in patients with the structural disease (104).”
Background
Metadata
- Authors
- Algeciras-Schimnich, A.
- Affiliations
- Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA
- Venue
- Critical Reviews in Clinical Laboratory Sciences
- Publisher
- Informa UK Limited
- Published
- 2018-03-16
- Volume
- 55
- Issue
- 3
- Pages
- 205-218
- ISSN
- 1040-8363 (ISSN-L)
- 1549-781X
- OpenAlex
- W2790937305
- Cited by
- 63
- References
- 100
- Citations by year
- 2026: 5 · 2025: 9 · 2024: 6 · 2023: 11 · 2022: 14 · 2021: 8 · 2020: 8 · 2019: 2
- FWCI
- 0.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Critical Reviews in Clinical Laboratory Sciences (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
- Keywords
- thyroglobulin, differentiated thyroid cancer, thyroglobulin antibodies, heterophile antibodies, assay interference, radioimmunoassay, immunometric assay, tumor markers, postoperative monitoring, recurrence
- MeSH terms
- Autoantibodies, Humans, Thyroglobulin, Thyroid Neoplasms, Biomarkers, Tumor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Thyroglobulin measurement in the management of patients with differentiated thyroid cancer. https://app.cochat.ai/papers/10.1080/10408363.2018.1450830
- The paper
- Algeciras-Schimnich, A. (2018). Thyroglobulin measurement in the management of patients with differentiated thyroid cancer. Critical Reviews in Clinical Laboratory Sciences. https://doi.org/10.1080/10408363.2018.1450830
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.